Catalyst Wire Dossier Catalyst Wire Dossier

BIBF 1120

nintedanib · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

36 regulatory and trial events tracked for BIBF 1120, covering 2012-10-04 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer [Phase 1]

See pricing